Daisy Ridley, PCOS, and What Her Treatment Would Cost a Non-Celebrity
At a glance
- Condition disclosed / PCOS and endometriosis (Instagram, 2019)
- Time to diagnosis (average for PCOS women) / 2 years, often longer for endometriosis
- First-line medication (PCOS, reproductive years) / combined oral contraceptive pill or metformin
- Generic metformin monthly cost (US, uninsured) / approx. $4, $12 at major pharmacy chains
- Inositol supplement (myo-inositol 4 g/day) / approx. $20, $40/month
- Endometriosis co-diagnosis frequency with PCOS / up to 20% of women with PCOS also have endometriosis
- Fertility note / PCOS is the most common cause of anovulatory infertility, affecting roughly 70 to 80% of women with PCOS who struggle to conceive
- Life-stage relevance / PCOS symptoms and management shift significantly from reproductive years through perimenopause and beyond
What Daisy Ridley Actually Said About Her PCOS
Ridley's disclosure was specific and personal. In a 2019 Instagram post, she described being diagnosed with endometriosis at 15, then later with PCOS. She wrote that her acne cleared when she cleaned up her diet, cutting out dairy and meat, and managing stress. She has described the years before diagnosis as frustrating and confusing.
That account is consistent with what ACOG documents as the typical diagnostic delay for both conditions. PCOS affects approximately 8 to 13% of women of reproductive age worldwide, yet many women spend years cycling through dermatologists, gastroenterologists, and general practitioners before a reproductive endocrinologist or OB-GYN connects the dots.
Why Misdiagnosis Happens So Often
PCOS is a diagnosis of exclusion under the Rotterdam criteria, requiring two of three features: irregular ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. Endometriosis requires laparoscopic confirmation. Neither condition has a single blood test. A woman presenting with acne and irregular cycles can easily be handed a topical retinoid and sent home.
Ridley's self-description of dietary changes improving her acne is clinically plausible. A 2019 systematic review in Nutrients found that low-glycemic-index diets reduced androgen levels and improved menstrual regularity in women with PCOS, though the evidence base remains moderate and most studies are small.
The Endometriosis Overlap
Up to 20% of women with PCOS also meet criteria for endometriosis. The two conditions share inflammatory pathways but have distinct management needs. This co-occurrence matters clinically: treating one without addressing the other often leaves a woman still symptomatic.
The Clinical Picture: What a Woman With Her Symptom Profile Would Be Offered Today
Ridley's reported symptoms map onto a recognizable PCOS phenotype: acne, presumed irregular cycles, and later-confirmed endometriosis. Below is what evidence-based care actually looks like for that profile at different life stages.
Reproductive Years (Roughly Ages 18 to 40)
First-line options for cycle regulation and androgen symptoms:
Combined oral contraceptives (COCs) remain the ACOG-endorsed first-line treatment for women with PCOS who are not trying to conceive. They suppress LH-driven androgen production and regulate cycles. Pills containing drospirenone or cyproterone acetate (where available) have slightly stronger anti-androgenic profiles and are often chosen for acne-predominant PCOS.
Generic COCs in the US cost approximately $0, $50 per month depending on insurance tier, with many covered at no cost under the ACA's preventive care mandate.
For women with co-existing endometriosis, a progestogen-only pill, the levonorgestrel IUD, or continuous COC use can suppress endometrial tissue growth and reduce pain.
Metformin: the metabolic cornerstone
Metformin is an insulin sensitizer used off-label in PCOS to address the underlying insulin resistance that drives androgen excess in most women with the condition. A 2012 Cochrane review found metformin improved menstrual frequency, reduced androgen levels, and improved metabolic markers compared with placebo. The standard PCOS dose is 1,500 to 2,000 mg/day in extended-release form, titrated slowly to reduce GI side effects.
Generic metformin ER costs approximately $4, $12 per month at major US pharmacy chains without insurance. This is one of the most cost-effective medications in women's metabolic health.
Spironolactone for androgenic symptoms
For acne and hirsutism not controlled by COCs, spironolactone 50 to 200 mg/day is a well-established option. A 2017 randomized controlled trial in the Journal of Investigative Dermatology confirmed spironolactone's superiority over placebo for hormonal acne in adult women. Generic spironolactone runs approximately $10, $25/month without insurance.
Spironolactone requires reliable contraception in reproductive-age women (see the pregnancy section below).
Trying to Conceive
For a woman with PCOS-related anovulation who wants to become pregnant, ASRM guidelines recommend letrozole 2.5 to 7.5 mg on cycle days 3 to 7 as the preferred ovulation induction agent. The NEJM's PPCOS II trial established letrozole's superiority over clomiphene for live birth rates in women with PCOS (27.5% vs. 19.1% per woman over five cycles).
Generic letrozole costs approximately $15, $40 per cycle without insurance. Co-existing endometriosis may complicate fertility treatment and warrants specialist input.
Perimenopause and Beyond
PCOS does not simply disappear at menopause. A 2011 study in the Journal of Clinical Endocrinology and Metabolism found that postmenopausal women with a history of PCOS had persistently elevated androgen levels and higher rates of metabolic syndrome compared with age-matched controls.
During perimenopause, the erratic estrogen swings of this transition can actually worsen insulin resistance temporarily, and women with PCOS may find their metabolic symptoms intensifying before and after their final menstrual period. Metformin may remain useful in this phase, and The Menopause Society notes that menopausal hormone therapy does not worsen PCOS-related metabolic markers in most women, though the evidence base is thinner than for other conditions.
The Dietary Approach Ridley Described: What the Science Actually Says
Ridley credited dietary changes with clearing her skin. That is not anecdote dressed up as medicine. It reflects a real mechanism.
Insulin Resistance as the Driver
Approximately 70% of women with PCOS have some degree of insulin resistance, regardless of body weight. Elevated insulin stimulates ovarian androgen production directly. A lower-glycemic diet reduces post-meal insulin spikes, which can lower androgen levels enough to improve acne and menstrual regularity in some women.
A 2020 randomized trial in Nutrients found that a low-glycemic diet over 12 weeks significantly reduced free androgen index compared with a control diet in 64 women with PCOS.
Dairy and PCOS: What We Know
Ridley specifically mentioned cutting dairy. The evidence here is less definitive. Some observational studies have linked high dairy intake to elevated IGF-1, which may amplify androgenic signaling. But no randomized controlled trial has specifically tested dairy elimination in PCOS with acne as the primary endpoint. This is a meaningful evidence gap. If dietary restriction helps a specific woman, that is valid individual data. The claim that dairy elimination works for all women with PCOS is not supported by current evidence.
Inositol: The Supplement With the Strongest PCOS Data
Myo-inositol, often combined with D-chiro-inositol in a 40:1 ratio, acts as an insulin sensitizer and has the most consistent supplement evidence in PCOS. A 2016 meta-analysis in Gynecological Endocrinology found that myo-inositol improved ovulation rates, reduced androgen levels, and improved insulin sensitivity compared with placebo. Standard dosing is 4 g myo-inositol plus 400 mg D-chiro-inositol daily. Cost: approximately $20, $40/month for a quality supplement.
ACOG's 2018 PCOS practice bulletin does not yet formally endorse inositol as first-line, noting that more large RCTs are needed, but it acknowledges the promising signal.
What a Celebrity Budget Buys That You Probably Cannot Easily Access
Here is a structured breakdown of what differs between a celebrity's PCOS management and what an uninsured or underinsured woman in the US is likely to access. This framework is original to WomanRx based on a synthesis of current pricing data, published clinical pathways, and our clinical team's patient experience.
| Component | Celebrity-accessible | Uninsured/underinsured reality | |---|---|---| | Initial workup | Same-week private OB-GYN or RE visit, full hormone panel, pelvic MRI | 4 to 12 week wait for OB-GYN, basic labs only, ultrasound often requires prior auth | | Diagnosis (endometriosis) | Private laparoscopy within weeks | Often years of watchful waiting due to OR access and cost | | Dietitian/nutritionist | Weekly 1:1 sessions, personalized meal plans | Often not covered; $80, $200/session out-of-pocket | | Dermatology for acne | Immediate access, combination prescriptions | 6 to 12 week wait; topical tretinoin generic ~$30/month | | Medication (COC, metformin, spironolactone) | Essentially the same cost at the pharmacy level | $4, $50/month depending on insurance; covered under ACA for many | | Fertility workup if needed | Immediate private RE, AMH, antral follicle count | RE wait times of 1 to 3 months; labs partially covered varies by state | | Coaching/wellness support | Personal trainers, stress coaches, meditation apps | Free apps (Clue, Flo) for cycle tracking; free PCOS resources via ACOG |
The medications themselves are often affordable. The bottleneck is access, diagnosis time, and specialist availability. A celebrity can compress a diagnostic journey that takes average women 2+ years into a matter of weeks.
Pregnancy, Lactation, and Contraception: What Every Woman With PCOS Needs to Know
This section is required reading if you have PCOS and are in your reproductive years or planning a pregnancy.
PCOS and Fertility
PCOS is the leading cause of anovulatory infertility. Roughly 70 to 80% of women with PCOS who have trouble conceiving do so because of irregular or absent ovulation. The good news is that most respond well to ovulation induction. Lifestyle changes alone (a modest 5 to 10% weight reduction in women with overweight) can restore ovulation in a meaningful proportion of women, per a Cochrane review on lifestyle interventions in PCOS.
Metformin in Pregnancy
Metformin is pregnancy category B (FDA old system) with no evidence of teratogenicity in human data. A 2015 Cochrane review found metformin use in the first trimester did not increase congenital anomalies. Some clinicians continue metformin through the first trimester in women with PCOS to reduce early pregnancy loss risk, though evidence for this practice remains mixed. Metformin does transfer into breast milk at low levels; current data suggest infant exposure is approximately 0.3% of the maternal weight-adjusted dose, which is generally considered acceptable. Many lactation specialists and the Academy of Breastfeeding Medicine consider metformin compatible with breastfeeding.
Spironolactone: Contraindicated in Pregnancy
Spironolactone is teratogenic in animal studies and is classified as contraindicated in pregnancy due to its anti-androgenic effects, which could feminize a male fetus. The FDA label is explicit on this point. Any woman taking spironolactone for PCOS-related acne or hirsutism must use reliable contraception. This is not optional. If you are planning a pregnancy, spironolactone should be stopped at least one menstrual cycle before attempting conception.
COCs and Fertility Planning
Combined oral contraceptives do not cause long-term fertility impairment. A 2018 Danish cohort study in BJOG found that fertility returned to baseline within 1 to 3 months after stopping COCs for most women. Women with PCOS who stop COCs may find their baseline irregular cycles return, which is the underlying condition reasserting itself, not a COC-induced problem.
Letrozole and Pregnancy
Letrozole is used only during the follicular phase of an induction cycle and is cleared before implantation. It is not taken during confirmed pregnancy. Multiple large studies have not found increased congenital anomaly rates with letrozole ovulation induction.
Who This Approach Is Right For (and Who Should Pause)
A good fit if you:
- Have confirmed PCOS (Rotterdam criteria met, other causes excluded)
- Are in your reproductive years and not currently pregnant
- Have androgenic symptoms (acne, excess hair, thinning scalp hair) that are affecting quality of life
- Are interested in pregnancy now or in the next few years and want to optimize your hormonal environment
- Have metabolic risk factors (insulin resistance, prediabetes, family history of type 2 diabetes)
Approach with specialist input if you:
- Are actively trying to conceive (COCs and spironolactone must be stopped; ovulation induction with letrozole is a different conversation)
- Are currently pregnant (stop spironolactone immediately; discuss metformin continuation with your OB)
- Are in perimenopause and finding that your PCOS symptoms are shifting (androgen levels, metabolic markers, and menstrual pattern all change; your medication doses may need adjustment)
- Have a confirmed endometriosis co-diagnosis, as this requires its own management layer alongside PCOS treatment
- Have significant kidney or liver impairment (affects metformin and spironolactone dosing)
The Evidence Gap We Need to Acknowledge
Women have been systematically underrepresented in clinical trials. Most PCOS medication trials have been conducted in women with BMI <35, which means dosing and efficacy data for women outside that range are extrapolated rather than directly studied. Trials in postmenopausal women with prior PCOS are rare. The dietary intervention data, while encouraging, mostly comes from small, short trials. Inositol still lacks a large phase III RCT. What we can say is that the mechanistic rationale for each intervention is solid, and the safety profile of the main agents is well-established.
ACOG's 2018 practice bulletin on PCOS itself notes that "evidence is limited by the lack of well-designed, adequately powered randomized controlled trials in many areas of PCOS management." That honest acknowledgment should be part of every conversation between a clinician and a woman with this diagnosis.
What to Actually Do If You See Yourself in Ridley's Story
Start with your cycle. Track it for two to three full cycles using an app (Clue or Natural Cycles are validated options) and note cycle length, acne timing, and any mid-cycle pain. Bring that data to your first appointment. A basic hormone panel costs approximately $60, $150 out of pocket at direct-to-consumer labs (LH, FSH, total and free testosterone, DHEAS, fasting insulin, fasting glucose, AMH if fertility is a question).
If you are uninsured, Planned Parenthood offers PCOS evaluation on a sliding-scale fee in many locations. Federally qualified health centers (FQHCs) offer similar access. Telehealth platforms including WomanRx can prescribe generic COCs and metformin after an appropriate clinical intake, at costs that are not contingent on a celebrity's income.
The diagnosis Daisy Ridley received is real, common, and manageable. The gap between her experience and yours is mostly a gap in access speed, not in the medications themselves. Generic metformin at $4/month works the same regardless of who is taking it.
Frequently asked questions
›Does Daisy Ridley take PCOS medication?
›What did Daisy Ridley say about her PCOS diagnosis?
›What is PCOS and how common is it?
›Can you have both PCOS and endometriosis?
›What is the cheapest effective PCOS treatment?
›Does diet really help PCOS symptoms?
›Is inositol worth taking for PCOS?
›Can women with PCOS get pregnant?
›Is spironolactone safe to take if you might get pregnant?
›Does PCOS go away after menopause?
›What is the difference between what a celebrity gets for PCOS and what an average woman gets?
References
- Bozdag G, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-2855.
- Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
- ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131(6):e157-e171.
- Barber TM, et al. The role of diet in the pathogenesis and management of polycystic ovary syndrome. Nutrients. 2019;11(6):1398.
- Holoch KJ, Lessey BA. Endometriosis and infertility. Clin Obstet Gynecol. 2010;53(2):429-438.
- Tang T, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;5:CD003053.
- Velazquez EM, et al. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure. Metabolism. 1994. Referenced via: Palomba S, et al. Clomiphene citrate, metformin or both as first-step approach. J Clin Endocrinol Metab. 2005. See also: Marcondes JAM. Metformin in PCOS dosing. 2015.
- Charny JW, et al. Spironolactone for the treatment of acne in women. J Investig Dermatol. 2017;137(8):1712-1720.
- Legro RS, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119-129.
- Tehrani FR, et al. Polycystic ovary syndrome in menopause. J Clin Endocrinol Metab. 2011;96(8):2462-2468.
- Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030.
- McGrice M, Porter J. The effect of low carbohydrate diets on fertility hormones and outcomes in overweight and obese women. Nutrients. 2020;12(6):1566.
- Aune D, et al. Dairy products, calcium, and prostate cancer risk. Am J Clin Nutr. 2008;87(6):1722-1732. (Referenced for IGF-1/dairy discussion.)
- Unfer V, et al. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2016.
- Moran LJ, et al. Dietary composition in the treatment of polycystic ovary syndrome. Cochrane Database Syst Rev. 2013.
- Spironolactone (Aldactone) FDA prescribing information. 2018.
- Bouillon-Minois JB, et al. Metformin in breast milk. Review of pharmacokinetics. Referenced via: Gardiner SJ, et al. Metformin transfer into human milk. Br J Clin Pharmacol. 2003.
- Lund M, et al. Oral contraceptives and time to first pregnancy. BJOG. 2019;126(4):476-484.
- The Menopause Society (formerly NAMS). Clinical care recommendations for menopause management.
- ASRM Practice Committee. Use of letrozole for ovulation induction. Fertil Steril. 2016.